This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd
Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery
This Might Also Be of Interest
Using pharmacokinetics to confirm bioequivalence in fluticasone DPIs
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions
COVID-19 intensifies need for and uptake of digital healthcare
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions
Exploring the role of EI in partnerships for OINDP development
Publications, Pharmaceutical, Product Solutions, Sustainability, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Market Insights
The Need to Scale Up Digital Health in the Post-Covid World
Webinars, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Brand Differentiation, Market Insights, Product Solutions